Psilera Bioscience
Since 2017, Scott is an Executive Director within the World Wide Hematology organization at Bristol Myers Squibb, formerly Celgene. Scott is an accomplished business executive with over 25 years of leadership experience in the healthcare field, primarily in the areas of diagnostics and personalized medicine for companies like Johnson & Johnson and Janssen. He holds a B.S. Degree in Biology with a Minor in Chemistry from Towson University, and an M. S. Degree in Business from Johns Hopkins University with a J & J Strategic Leadership Certificate from Harvard Business School.
This person is not in any teams
This person is not in any offices
Psilera Bioscience
Psilera will leverage its research strengths led by executives from the pharmaceutical and cannabis industries to develop a best-in-class IP portfolio of psychedelic analogues.